Karpas Strategies’s Bristol-Myers Squibb BMY Stock Holding History

Karpas Strategies’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	$1.38M	Buy	33,259 +17	+0.1%	+$761	0.43%	52
2024 Q1	$1.8M	Buy	33,242 +16	+0%	+$815	0.56%	44
2023 Q4	$1.7M	Buy	33,226 +14	+0%	+$735	0.56%	42
2023 Q3	$1.93M	Buy	33,212 +12	+0%	+$735	0.71%	38
2023 Q2	$2.12M	Buy	33,200 +10	+0%	+$671	0.72%	37
2023 Q1	$2.3M	Buy	33,190 +10	+0%	+$705	0.81%	36
2022 Q4	$2.39M	Buy	33,180 +8	+0%	+$603	0.84%	36
2022 Q3	$2.36M	Sell	33,172 -541	-2%	-$39.2K	0.9%	32
2022 Q2	$2.6M	Buy	33,713 +9	+0%	+$685	0.91%	32
2022 Q1	$2.46M	Buy	33,704 +904	+3%	+$60.7K	0.78%	36
2021 Q4	$2.04M	Hold	32,800	–	–	0.66%	35
2021 Q3	$1.92M	Hold	32,800	–	–	0.63%	37
2021 Q2	$2.19M	Hold	32,800	–	–	0.78%	33
2021 Q1	$2.07M	Hold	32,800	–	–	0.78%	34
2020 Q4	$2.04M	Buy	32,800 +720	+2%	+$44.3K	0.8%	33
2020 Q3	$1.93M	Hold	32,080	–	–	0.89%	28
2020 Q2	$1.89M	Hold	32,080	–	–	0.91%	32
2020 Q1	$1.79M	Hold	32,080	–	–	0.97%	28
2019 Q4	$2.06M	Hold	32,080	–	–	0.77%	36
2019 Q3	$1.63M	Hold	32,080	–	–	0.66%	37
2019 Q2	$1.46M	Sell	32,080 -60	-0.2%	-$2.79K	0.6%	39
2019 Q1	$1.53M	Buy	32,140 +60	+0.2%	+$2.99K	0.65%	39
2018 Q4	$1.67M	Hold	32,080	–	–	0.78%	36
2018 Q3	$1.99M	Hold	32,080	–	–	0.82%	36
2018 Q2	$1.77M	Hold	32,080	–	–	0.77%	36
2018 Q1	$2.03M	Hold	32,080	–	–	0.88%	32
2017 Q4	$1.97M	Hold	32,080	–	–	0.84%	35
2017 Q3	$2.04M	Hold	32,080	–	–	0.9%	31
2017 Q2	$1.79M	Hold	32,080	–	–	0.81%	34
2017 Q1	$1.75M	Hold	32,080	–	–	0.8%	34
2016 Q4	$1.88M	Buy	32,080 +480	+2%	+$26.2K	0.88%	33
2016 Q3	$1.7M	Hold	31,600	–	–	0.83%	33
2016 Q2	$2.32M	Hold	31,600	–	–	1.16%	26
2016 Q1	$2.02M	Hold	31,600	–	–	1.05%	30
2015 Q4	$2.17M	Hold	31,600	–	–	1.15%	26
2015 Q3	$1.87M	Hold	31,600	–	–	1.03%	31
2015 Q2	$2.1M	Hold	31,600	–	–	1.05%	30
2015 Q1	$2.04M	Hold	31,600	–	–	0.99%	31
2014 Q4	$1.86M	Hold	31,600	–	–	0.89%	33
2014 Q3	$1.62M	Hold	31,600	–	–	0.81%	33
2014 Q2	$1.53M	Hold	31,600	–	–	0.77%	35
2014 Q1	$1.64M	Hold	31,600	–	–	0.87%	34
2013 Q4	$1.68M	Hold	31,600	–	–	0.93%	34
2013 Q3	$1.46M	Hold	31,600	–	–	0.86%	36
2013 Q2	$1.41M	Buy	+31,600	New	+$1.37M	0.86%	34

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Karpas Strategies's BMY Position: Q2 2024 in Review

Karpas Strategies increased its Bristol-Myers Squibb (BMY) stake by 0.05% in Q2 2024, buying an estimated $761 and bringing the position to 33,259 shares worth $1.38M. The position accounts for 0.43% of the portfolio, ranked #52.

Karpas Strategies first reported a position in BMY in Q2 2013 and has held it in 45 quarters since. The position peaked at $2.6M in Q2 2022. 2,148 funds tracked by Wall St. Rank hold BMY as of Q2 2024.

Karpas Strategies held 33,259 shares of Bristol-Myers Squibb worth $1.38M as of Q2 2024.
Karpas Strategies bought 17 Bristol-Myers Squibb shares in Q2 2024, an estimated $761.
Bristol-Myers Squibb made up 0.43% of Karpas Strategies's portfolio in Q2 2024, its #52 holding.
Karpas Strategies first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 45 quarters since.
Karpas Strategies's Bristol-Myers Squibb position peaked at $2.6M in Q2 2022.
2,148 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2024.

Based on Karpas Strategies's 13F filing for Q2 2024, filed 30 Jul 2024.